Time to market for avatrombopag

Avatrombopag was launched in 2018 when it was launched by the American pharmaceutical company Dova Pharmaceuticals. Dova PharmaceuticalsFocuses on research and development in the fields of rare diseases and hematology, and is committed to providing innovative treatment options for patients.

In2018, the U.S. Food and Drug Administration (FDA) approved the marketing of avatrombopag as an oral medication for the treatment of adults with chronic immune thrombocytopenia (ITP). ITPIt is an autoimmune disease in which the patient's immune system mistakenly attacks and destroys platelets, resulting in a reduced number of platelets and an increased risk of bleeding.

The launch of avatrombopag provides a new treatment option forITP patients. Prior to this, the treatment of ITP mainly included corticosteroids, immunosuppressants, and plasma exchange, but these treatments may have some side effects or require long-term use. Therefore, the launch of avatrombopag fills a need in the ITP treatment area and provides patients with a new choice.

Since then, avatrombopag has been approved in other countries and regions and has been gradually launched on the market worldwide. The launch of the drug not only brings new treatment options toITP patients, but also provides doctors with more treatment options to provide personalized treatment according to the specific conditions of the patients.

Avatrombopag is now on the market in China and has been successfully included in the medical insurance system. Domestic patients can easily purchase this drug, and its price is roughly in the range of three to four thousand yuan. For detailed information on specific drug prices and medical insurance reimbursement, patients are advised to consult the pharmacy of their local hospital for accurate answers. In addition, compared with domestic prices, the price of generic avatrombopag on the market abroad is more affordable. It is mainly sold in Laos and Bangladesh, with prices ranging from a few hundred to a thousand yuan. It is worth mentioning that the ingredients of these generic drugs are basically the same as those of the original drugs.